These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7675645)

  • 1. [Radiation exposure in the vicinity of patients after administration of Tc-99m-DPD].
    Preitfellner J; Kurtaran A; Havlik E
    Nuklearmedizin; 1995 Aug; 34(4):151-5. PubMed ID: 7675645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.
    Willegaignon J; Guimarães MI; Stabin MG; Sapienza MT; Malvestiti LF; Marone MM; Sordi GM
    Health Phys; 2007 Dec; 93(6):678-88. PubMed ID: 17993848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation exposure after permanent prostate brachytherapy.
    Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
    Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiation exposure in the surrounding of patients after 201Tl myocardial scintigraphy].
    Kurtaran A; Preitfellner J; Kohoutek D; Tousek A; Virgolini I; Havlik E
    Nuklearmedizin; 1997 Jan; 36(1):29-31. PubMed ID: 9082338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex.
    Djokić DDj; Janković DLj; Nikolić NS
    Bioorg Med Chem; 2008 Apr; 16(8):4457-65. PubMed ID: 18331797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
    Kriehuber R; Kadenbach K; Schultz F; Weiss DG
    Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
    Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
    Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient dosimetry of intravenously administered 99mTc-annexin V.
    Kemerink GJ; Liem IH; Hofstra L; Boersma HH; Buijs WC; Reutelingsperger CP; Heidendal GA
    J Nucl Med; 2001 Feb; 42(2):382-7. PubMed ID: 11216539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation safety implications of 131I treatment in a patient with Grave's disease undergoing home hemodialysis.
    Simpson JB; Godwin GA
    Health Phys; 2006 Dec; 91(6):570-3. PubMed ID: 17099400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures].
    Sudbrock F; Boldt F; Kobe C; Hammes J; Eschner W; Schicha H
    Nuklearmedizin; 2009; 48(1):17-25. PubMed ID: 19212607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F protection issues: human and gamma-camera considerations.
    Cao Z; Corley JH; Allison J
    J Nucl Med Technol; 2003 Dec; 31(4):210-5. PubMed ID: 14657287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Work to save dose: contrasting effective dose rates from radon exposure in workplaces and residences against the backdrop of public and occupational regulatory limits.
    Whicker JJ; McNaughton MW
    Health Phys; 2009 Sep; 97(3):248-56. PubMed ID: 19667808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy.
    Dauer LT; Zelefsky MJ; Horan C; Yamada Y; St Germain J
    Brachytherapy; 2004; 3(1):1-6. PubMed ID: 15110306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effective radiation doses of the personnel at rentgenosurgical studies].
    Lebedev LA; Blinov AB; Lobov DP; Mikheenko SG
    Med Tekh; 2005; (3):11-4. PubMed ID: 16106952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and absorbed radiation dose estimates of 99mTc-labeled dimercaptopropionyl human serum albumin.
    van Aswegen A; Marais J; Kemp G; Nel MG; van Staden JA; Otto AC; Lötter MG; Verbruggen AM
    J Nucl Med; 1999 Sep; 40(9):1532-5. PubMed ID: 10492376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External radiation doses to nuclear medicine technologists from procedures using 99mTc radiopharmaceuticals.
    Boutcher S; Haas T
    Can J Radiogr Radiother Nucl Med; 1985 Oct; 16(4):161-5. PubMed ID: 10274037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.